Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AzaSite vs Tobramycin in Bacterial Conjunctivitis
NCT00105469Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AzaSite in bacterial conjunctivitis (BC), sponsored by Merck & Co.. Started Jul 2004; status: completed.
02
Drugs
AzaSite
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00105469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105469.